Archive for ADHD in Canada
In Canada, there is a generic Concerta available. It’s called: Teva-Methylphenidate ER-C (it was formerly called: Novo-Methylphenidate ER-C). Many people have had trouble with this generic, and it is widely accepted by doctors in Canada and patients that the generic doesn’t work as well as the brand name concerta.
Vyvanse (lisdexamfetamine) is one of the newer medications for ADHD. It has been in Canada since February 2010. However, the provincial insurance plans did not cover it.
I’m pleased to announce that as of June 8, 2011, Vyvanse will be covered by the Ontario Drug Plan. This means that if a family has an Ontario drug card (from being on OW, or ODSP, or a child disability, or even the Trillium Drug Plan), then Vyvanse will be covered.
I’m writing this post to let you know that I will be speaking live for the Learning Disability Association of Mississauga on Thursday April 14th from 7-9 pm. Registration is at 6:30 pm.
The title of this talk: Attention Difference Disorder: How to Turn Your ADHD Child or Teen’s Differences into Strengths in 7 Simple Steps.
Updated February 2, 2011
There have been several articles about generic medicines on this blog – many of which have generated significant discussion amongst this blog’s readers. All of the previous articles have been about generic stimulant medicine.
This is the first article about a generic non-stimulant – i.e. Strattera.
Updated January 3, 2011:
Vyvanse was officially launched in Canada on February 1, 2010.
When it was first launched – it was only officially approved for use in children – aged 6-12 years old. As of November 2010, Vyvanse is now officially indicated for use in ADHD in children (6-12 years old), teenagers (13-18 years old), and adults (18-65 years old). This means that Vyvanse is now officially indicated in Canada for use in ADHD ‘across the lifespan’ – i.e. from childhood to adulthood.
It is with sadness that I report that a doctor who was a true leader in ADHD in Canada and internationally passed away on April 8, 2010.
Dr. Atila Turgay had recently created the ‘Toronto ADHD Clinic’, where he was seeing a large number of children, teens and adults for ADHD. This was a service which was desperately needed, and it was particularly helpful that Dr. Turgay brought such expertise to this clinic. I am hopeful that after Dr. Turgay’s passing, that some of the other doctors who had started to help with this clinic will in fact carry on the important work that was started by Dr. Turgay.
Generic Concerta was introduced into Canada around February 2010. As I’ve written in my full article about Generic Concerta – I’m quite concerned about the fact that the new generic medicine does not have the same properties as brand name Concerta – and this may lead to problems for patients who are automatically switched from brand name Concerta to Novo-Methylphenidate ER C.
I am pleased to let you know that I will be speaking at the Centre for ADD/ADHD Advocacy Canada (CADDAC) conference on April 24th, 2010.
This is a weekend conference in Toronto, which will focus on many important aspects of ADD/ADHD. On the Saturday, the conference will focus mostly on child ADD/ADHD, and on the Sunday, it will focus mostly on Adolescent and Adult ADD/ADHD. The Saturday night will have a Comedy night – which will be very entertaining and help to raise funds to support advocacy for ADD/ADHD across Canada.
February 14, 2010
Vyvanse was launched in Canada officially on February 1st, 2010. Even though it was officially launched, there have been some issues with the ability of pharmacies to get Vyvanse on their shelves.
*This article has been updated on May 30, 2010.
Concerta is a long acting preparation of Methylphenidate. It was launched in the US in 2000, and in Canada in 2003.